Table 3.

General linear model of associations between substance use and Centers for Disease Control and Prevention guideline adherence, accounting for covariates in the full sample of survey participants (N=1084).

Variable		Unstandardized estimate	95% CI
Intercept		2.26	2.19 to 2.37
Gender
	Cisgender female	Refa	Ref
	Cisgender male	−0.17	−0.24 to −0.10
	Other gender identity or prefer not to answer	−0.42	−0.62 to −0.21
Hispanic or Latino (Ref: No)		−0.05	−0.13 to 0.03
Essential worker (Ref: No)		−0.04	−0.13 to 0.04
Income		0.02	0.004 to 0.04
COVID-19 test
	No test or unsure	Ref	Ref
	Negative test	0.10	0.01 to 0.19
	Positive test	−0.02	−0.21 to 0.17
Alcohol use (past 7 days)
	Daily versus none	−0.07	−0.20 to 0.06
	1-6 days versus none	0.10	0.02 to 0.17
	Daily versus 1-6 daysb	−0.16	−0.30 to −0.02
Opioid use
	Daily versus none	−0.57	−0.76 to −0.38
	1-6 days versus none	−0.32	−0.43 to −0.22
	Daily versus 1-6 daysb	−0.24	−0.44 to −0.05

^aRef: reference category.

^bIndicates reference groups and additional models for substance use variables where reference groups were switched to allow for additional comparisons.